Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alborz Darou is a prominent Iranian pharmaceutical company headquartered in Tehran, with its primary manufacturing facilities located in the Alborz Industrial City of Qazvin. Founded in 1976, the company specializes in the development and production of a diverse range of human pharmaceuticals, including cardiovascular, central nervous system, and gastrointestinal medications. As a publicly-traded entity on the Tehran Stock Exchange, it is one of the largest pharmaceutical producers in Iran by volume. The company's portfolio consists primarily of generic small molecule drugs, and it maintains high-standard GMP manufacturing lines for tablets, capsules, and injectables. Alborz Darou is a subsidiary of the Barekat Pharmaceutical Group, playing a critical role in the Iranian domestic drug supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alborz Darou.